Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents.

The innate immune system provides rapid and effective host defense against microbial invasion in a manner that is independent of prior exposure to a given pathogen. It has long been appreciated that the blood contains important elements that mediate rapid responses to infection. Thus, anatomic compartments with ample blood supply are less frequently infected and recover more readily once infected, whereas regions with poor perfusion are prone to severe infection and may require surgical debridement. Blood-borne innate immune mediators are either carried in circulating blood cells (ie, leukocytes and platelets) or in plasma after release from blood cells or on secretion by the liver. (Blood. 2000;96:2664-2672)

[1]  S. Iwanaga,et al.  The role of hemolymph coagulation in innate immunity. , 1996, Current opinion in immunology.

[2]  T. Yip,et al.  Bactericidal domain of lactoferrin: detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry. , 1998, Biochemical and biophysical research communications.

[3]  P. Nicolas,et al.  The dermaseptin precursors: a protein family with a common preproregion and a variable C‐terminal antimicrobial domain , 1999, FEBS letters.

[4]  F. Oski,et al.  Hematology of Infancy and Childhood , 1974 .

[5]  M. Knowles,et al.  Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects. , 1997, The Journal of clinical investigation.

[6]  P. Nibbering,et al.  Ubiquicidin, a novel murine microbicidal protein present in the cytosolic fraction of macrophages , 1999, Journal of leukocyte biology.

[7]  T. Nevalainen,et al.  Protection by group II phospholipase A2 against Staphylococcus aureus. , 1999, Journal of immunology.

[8]  A. van Dorsselaer,et al.  Insect immunity. The inducible antibacterial peptide diptericin carries two O-glycans necessary for biological activity. , 1995, Biochemistry.

[9]  R. Hancock,et al.  Interaction of Cationic Peptides with Lipoteichoic Acid and Gram-Positive Bacteria , 1999, Infection and Immunity.

[10]  R. M. Smith,et al.  Molecular basis of chronic granulomatous disease. , 1991, Blood.

[11]  J. Stirling.  Ultrastructural localization of lysozyme in human colon eosinophils using the protein A-gold technique: effects of processing on probe distribution. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[12]  H. Baker,et al.  Structure of human lactoferrin at 3.2-A resolution. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. G. Hirsch.  PHAGOCYTIN: A BACTERICIDAL SUBSTANCE FROM POLYMORPHONUCLEAR LEUCOCYTES , 1956, The Journal of experimental medicine.

[14]  N. Fujii,et al.  Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. , 1995, Biochemistry.

[15]  E. De Clercq,et al.  Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. , 1995, The Journal of infectious diseases.

[16]  M. Ptak,et al.  Penetration of the insect defensin A into phospholipid monolayers and formation of defensin A-lipid complexes. , 1997, Biophysical journal.

[17]  H. Murray,et al.  Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity. , 1983, The Journal of clinical investigation.

[18]  J. Murray,et al.  Antimicrobial properties of human lysozyme transgenic mouse milk. , 1998, Journal of food protection.

[19]  M. Doerfler,et al.  Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins. , 1995, Journal of immunology.

[20]  G. Gleich,et al.  Toxic effects produced or mediated by human eosinophil granule components on Trypanosoma cruzi. , 1988, The American journal of tropical medicine and hygiene.

[21]  C. Nathan,et al.  Nitric oxide and macrophage function. , 1997, Annual review of immunology.

[22]  James M. Wilson,et al.  Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis , 1997, Cell.

[23]  P. Gros,et al.  Macrophage NRAMP1 and its role in resistance to microbial infections , 1998, Inflammation Research.

[24]  S. White,et al.  Structure, function, and membrane integration of defensins. , 1995, Current opinion in structural biology.

[25]  J. Trapani,et al.  Granzymes: a variety of serine protease specificities encoded by genetically distinct subfamilies , 1996, Journal of leukocyte biology.

[26]  Jun Yuan,et al.  A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. , 1999, Science.

[27]  O. Levy,et al.  Enhancement of Neonatal Innate Defense: Effects of Adding an N-Terminal Recombinant Fragment of Bactericidal/Permeability-Increasing Protein on Growth and Tumor Necrosis Factor-Inducing Activity of Gram-Negative Bacteria Tested in Neonatal Cord Blood Ex Vivo , 2000, Infection and Immunity.

[28]  P. Elsbach,et al.  High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide , 1992, Infection and immunity.

[29]  J. Larrick,et al.  Evaluation of Antimicrobial and Lipopolysaccharide-Neutralizing Effects of a Synthetic CAP18 Fragment against Pseudomonas aeruginosa in a Mouse Model , 1998, Antimicrobial Agents and Chemotherapy.

[30]  D. Hultmark.  Insect lysozymes. , 1996, EXS.

[31]  P. Fehlbaum,et al.  Insect immunity. Septic injury of Drosophila induces the synthesis of a potent antifungal peptide with sequence homology to plant antifungal peptides. , 1994, The Journal of biological chemistry.

[32]  R. Lehrer.  Holocrine secretion of calprotectin: a neutrophil-mediated defense against Candida albicans? , 1993, The Journal of laboratory and clinical medicine.

[33]  R. Hancock,et al.  Improved activity of a synthetic indolicidin analog , 1997, Antimicrobial agents and chemotherapy.

[34]  M. Zasloff,et al.  Potential therapeutic applications of magainins and other antimicrobial agents of animal origin. , 2007, Ciba Foundation symposium.

[35]  P. Elsbach,et al.  Role of the bactericidal/permeability-increasing protein in host defence. , 1998, Current opinion in immunology.

[36]  G. Gleich,et al.  Localization of eosinophil granule major basic protein in paracoccidioidomycosis lesions. , 1998, The American journal of tropical medicine and hygiene.

[37]  C. E. Ooi,et al.  Individual and synergistic effects of rabbit granulocyte proteins on Escherichia coli. , 1994, The Journal of clinical investigation.

[38]  E. Rietschel,et al.  Mechanisms of action of the bactericidal/permeability-increasing protein BPI on endotoxin and phospholipid monolayers and aggregates. , 1997, Biochemistry.

[39]  A. Kettle,et al.  Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. , 1998, Blood.

[40]  A. Bayer,et al.  In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates , 1994, Antimicrobial Agents and Chemotherapy.

[41]  R. Bals,et al.  Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. , 1999, The Journal of clinical investigation.

[42]  M. Yeaman.  The role of platelets in antimicrobial host defense. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  R. L. Barker,et al.  In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins. , 1990, Journal of immunology.

[44]  P. Elsbach,et al.  Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. , 1992, The Journal of clinical investigation.

[45]  R. Hancock,et al.  Cutting Edge: Cationic Antimicrobial Peptides Block the Binding of Lipopolysaccharide (LPS) to LPS Binding Protein1 , 2000, The Journal of Immunology.

[46]  A. Johnsen,et al.  The Human Antibacterial Cathelicidin, hCAP-18, Is Bound to Lipoproteins in Plasma* , 1999, The Journal of Biological Chemistry.

[47]  C. Nathan,et al.  Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties. , 1990, The Journal of clinical investigation.

[48]  J. Crawford,et al.  Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. , 1998, The Journal of clinical investigation.

[49]  M. Heinzelmann,et al.  Heparin-binding protein (CAP37) is internalized in monocytes and increases LPS-induced monocyte activation. , 1998, Journal of immunology.

[50]  P. Tobias,et al.  Lipopolysaccharide (LPS)-binding Proteins BPI and LBP Form Different Types of Complexes with LPS* , 1997, The Journal of Biological Chemistry.

[51]  C. Roumestand,et al.  Oligomerization of protegrin‐1 in the presence of DPC micelles. A proton high‐resolution NMR study , 1998, FEBS letters.

[52]  John I. Gallin,et al.  Inflammation: Basic Principles and Clinical Correlates , 1992 .

[53]  P. Gros,et al.  Infection genomics: Nramp1 as a major determinant of natural resistance to intracellular infections. , 1998, Annual review of medicine.

[54]  Stephen Naylor,et al.  A Novel and Highly Divergent Homolog of Human Eosinophil Granule Major Basic Protein* , 1999, The Journal of Biological Chemistry.

[55]  Mats Andersson,et al.  NK-lysin, a Disulfide-containing Effector Peptide of T-lymphocytes, Is Reduced and Inactivated by Human Thioredoxin Reductase , 1996, The Journal of Biological Chemistry.

[56]  P. Tempst,et al.  Lethal Effects of Apidaecin on Escherichia coliInvolve Sequential Molecular Interactions with Diverse Targets* , 1999, The Journal of Biological Chemistry.

[57]  H. G. Boman,et al.  Peptide antibiotics and their role in innate immunity. , 1995, Annual review of immunology.

[58]  Vanya Gant,et al.  Structure-Function Relationship of Antibacterial Synthetic Peptides Homologous to a Helical Surface Region on Human Lactoferrin against Escherichia coli Serotype O111 , 1998, Infection and Immunity.

[59]  T. Ley,et al.  The role of granzyme B cluster proteases in cell-mediated cytotoxicity. , 1997, Seminars in immunology.

[60]  T. Ganz,et al.  The Role of Protegrins and Other Elastase-Activated Polypeptides in the Bactericidal Properties of Porcine Inflammatory Fluids , 1998, Infection and Immunity.

[61]  T. Ganz,et al.  Antimicrobial peptides of phagocytes and epithelia. , 1997, Seminars in hematology.

[62]  J. Weiss,et al.  Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2. , 1998, The Journal of clinical investigation.

[63]  E. Valore,et al.  The structure of the rabbit macrophage defensin genes and their organ-specific expression. , 1989, Journal of immunology.

[64]  M. Yazdanbakhsh,et al.  Bactericidal action of eosinophils from normal human blood , 1986, Infection and immunity.

[65]  A. Eerenberg,et al.  Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein. , 1995, The Journal of infectious diseases.

[66]  M. Ghannoum,et al.  Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro , 1993, Antimicrobial Agents and Chemotherapy.

[67]  A. Tager,et al.  The effect of chloride concentration on human neutrophil functions: potential relevance to cystic fibrosis. , 1998, American journal of respiratory cell and molecular biology.

[68]  P. Sohnle,et al.  The zinc-reversible antimicrobial activity of neutrophil lysates and abscess fluid supernatants. , 1991, The Journal of infectious diseases.

[69]  T. Ganz,et al.  Defensins and other endogenous peptide antibiotics of vertebrates , 1995, Journal of leukocyte biology.

[70]  P. Sohnle,et al.  Histidine-based zinc-binding sequences and the antimicrobial activity of calprotectin. , 1998, The Journal of infectious diseases.

[71]  B. Giroir,et al.  Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis , 1997, The Lancet.

[72]  B. Schonwetter,et al.  Epithelial antibiotics induced at sites of inflammation. , 1995, Science.

[73]  Domenico Romeo,et al.  Cathelicidins: a novel protein family with a common proregion and a variable C‐terminal antimicrobial domain , 1995, FEBS letters.

[74]  V. Mutt,et al.  NK‐lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity. , 1995, The EMBO journal.

[75]  T. Nyström,et al.  Attacin--an insect immune protein--binds LPS and triggers the specific inhibition of bacterial outer-membrane protein synthesis. , 1998, Microbiology.

[76]  P. Bulet,et al.  Antimicrobial peptides in insects; structure and function. , 1999, Developmental and comparative immunology.

[77]  J. Crawford,et al.  Tumor Necrosis Factor – a Production to Lipopolysaccharide Stimulation by Donor Cells Predicts the Severity of Experimental Acute Graft-Versus-Host Disease , 1998 .

[78]  J. Hoffmann,et al.  Innate immunity in higher insects. , 1996, Current opinion in immunology.

[79]  V. Salmon,et al.  Lactoferrin Inhibits the Endotoxin Interaction with CD14 by Competition with the Lipopolysaccharide-Binding Protein , 1998, Infection and Immunity.

[80]  J. Odeberg,et al.  The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. , 1996, European journal of biochemistry.

[81]  Wangkun Lee,et al.  The Protective Effects of Lactoferrin Feeding against Endotoxin Lethal Shock in Germfree Piglets , 1998, Infection and Immunity.

[82]  P. Szejda,et al.  Comparison of intracellular bactericidal activities of human neutrophils and eosinophils. , 1978, Blood.

[83]  S. Grinstein,et al.  Host Resistance to Intracellular Infection: Mutation of Natural Resistance-associated Macrophage Protein 1 (Nramp1) Impairs Phagosomal Acidification , 1998, The Journal of experimental medicine.

[84]  P. Elsbach,et al.  Oxygen-independent intracellular and oxygen-dependent extracellular killing of Escherichia coli S15 by human polymorphonuclear leukocytes. , 1985, The Journal of clinical investigation.

[85]  W. Foss,et al.  Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action. , 1998, The Journal of clinical investigation.

[86]  D Eisenberg,et al.  Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. , 1997, Science.

[87]  R. Tapping,et al.  Endotoxin interactions with lipopolysaccharide-responsive cells. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[88]  E. Boix,et al.  Recombinant Human Eosinophil Cationic Protein , 2000 .

[89]  P. Elsbach,et al.  Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli , 1994, Infection and immunity.

[90]  T. Ganz,et al.  An antimicrobial activity of cytolytic T cells mediated by granulysin. , 1998, Science.

[91]  O. Levy,et al.  Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein. , 1999 .

[92]  M. N. Marra,et al.  Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity. , 1990, Journal of Immunology.

[93]  R. D. de Winter,et al.  Recombinant endotoxin-binding protein (rBPI23) attenuates endotoxin-induced circulatory changes in humans. , 1995, Journal of inflammation.

[94]  H. Wigzell,et al.  The Expression of the Gene Coding for the Antibacterial Peptide LL-37 Is Induced in Human Keratinocytes during Inflammatory Disorders* , 1997, The Journal of Biological Chemistry.

[95]  D. Eisenberg,et al.  Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. , 1991, Science.

[96]  D. Golenbock,et al.  LPS‐binding proteins and receptors , 1998, Journal of leukocyte biology.

[97]  V. Bafna,et al.  Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. , 1998, The Journal of clinical investigation.

[98]  A. Bayer,et al.  Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein , 1992, Infection and immunity.

[99]  T. Ganz,et al.  Inhibition of intracellular Histoplasma capsulatum replication by murine macrophages that produce human defensin , 1994, Infection and immunity.

[100]  J. Hoffmann,et al.  Innate immunity of insects. , 1995, Current opinion in immunology.

[101]  H. Kita,et al.  Localization of eosinophil‐derived neurotoxin and eosinophil cationic protein in neutrophilic leukocytes , 1998, Journal of leukocyte biology.

[102]  J. Fiddes,et al.  Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity , 1997, Antimicrobial agents and chemotherapy.

[103]  P. Elsbach,et al.  The bactericidal/permeability‐increasing protein (BPI) in antibacterial host defense , 1998, Journal of leukocyte biology.

[104]  P. Sohnle,et al.  Inhibition of pseudohyphal growth as a neutrophil-mediated host defense mechanism against experimental deep Candida albicans infections in mice. , 1993, The Journal of laboratory and clinical medicine.

[105]  A. Bayer,et al.  Effect of thrombocytopenia on the early course of streptococcal endocarditis. , 1993, The Journal of infectious diseases.

[106]  Christina H. Park,et al.  Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. , 1998, The Journal of clinical investigation.

[107]  D. Dunn,et al.  Macrophages expressing a fusion protein derived from bactericidal/permeability-increasing protein and IgG are resistant to endotoxin. , 1996, Archives of surgery.

[108]  W. Buurman,et al.  Bactericidal/permeability-increasing protein, a lipopolysaccharide-specific protein on the surface of human peripheral blood monocytes. , 1996, The Journal of infectious diseases.

[109]  U Seydel,et al.  Mechanisms of action of bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of gram-negative bacteria. , 1997, Biochemistry.

[110]  H. Erdjument-Bromage,et al.  Biodiversity of apidaecin-type peptide antibiotics. Prospects of manipulating the antibacterial spectrum and combating acquired resistance. , 1994, The Journal of biological chemistry.

[111]  O. Levy,et al.  Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate. , 1995, The Journal of clinical investigation.

[112]  G. Garcı́a-Cardeña,et al.  Bacterial infection induces nitric oxide synthase in human neutrophils. , 1997, The Journal of clinical investigation.

[113]  M. Vadas,et al.  Interactions between human eosinophils and schistosomula of schistosoma mansoni. II. The mechanism of irreversible eosinophil adherence , 1979, The Journal of experimental medicine.

[114]  O. Levy,et al.  Impaired Innate Immunity in the Newborn: Newborn Neutrophils Are Deficient in Bactericidal/Permeability-Increasing Protein (BPI) , 1999, Pediatrics.

[115]  P. Elsbach,et al.  An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[116]  H. Rosenberg,et al.  The bactericidal/permeability-increasing protein (BPI) is present in specific granules of human eosinophils. , 1998, Blood.

[117]  B. Babior.  NADPH oxidase: an update. , 1999, Blood.

[118]  H. Ibrahim,et al.  Bactericidal action of lysozymes attached with various sizes of hydrophobic peptides to the C‐terminal using genetic modification , 1997, FEBS letters.

[119]  M. Willcox,et al.  Synergic antistaphylococcal properties of lactoferrin and lysozyme. , 1998, Journal of medical microbiology.

[120]  A. Molina,et al.  Plant defense peptides. , 1998, Biopolymers.

[121]  J. Fiddes,et al.  Effect of local application of the antimicrobial peptide IB-367 on the incidence and severity of oral mucositis in hamsters. , 1999, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[122]  F. Sigaux,et al.  Acquisition of granzyme B and Fas ligand proteins by human keratinocytes contributes to epidermal cell defense. , 1997, Journal of immunology.

[123]  P. Godowski,et al.  The toll of innate immunity on microbial pathogens. , 1999, The New England journal of medicine.

[124]  F C Kafatos,et al.  Phylogenetic perspectives in innate immunity. , 1999, Science.

[125]  P. Venge,et al.  Mechanism of membrane damage mediated by human eosinophil cationic protein , 1986, Nature.

[126]  P. Elsbach,et al.  p15s (15-kD antimicrobial proteins) are stored in the secondary granules of Rabbit granulocytes: implications for antibacterial synergy with the bactericidal/permeability-increasing protein in inflammatory fluids. , 1997, Blood.

[127]  T. Ganz,et al.  Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. , 1989, Journal of immunology.

[128]  Ofer Levy,et al.  Antibiotic proteins of polymorphonuclear leukocytes , 1996, European journal of haematology.

[129]  K. Miyasaki,et al.  Human neutrophil azurocidin synergizes with leukocyte elastase and cathepsin G in the killing of Capnocytophaga sputigena , 1992, Infection and immunity.

[130]  J. Larrick,et al.  Structure and functions of endotoxin-binding peptides derived from CAP18. , 1995, Progress in clinical and biological research.

[131]  N. Hogg,et al.  MRP‐8 and MRP‐14, two abundant Ca2+‐binding proteins of neutrophils and monocytes , 1993, Journal of leukocyte biology.

[132]  T. Habermann,et al.  Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. , 1997, The New England journal of medicine.

[133]  Ronald McCarthy,et al.  Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis , 1998, Nature Medicine.

[134]  P. Ehrlich.  Granules of the Human Neutrophilic Polymorphonuclear Leukocyte , 1997 .

[135]  R. Lehrer,et al.  Secretory Phospholipase A2 Is the Principal Bactericide for Staphylococci and Other Gram-Positive Bacteria in Human Tears , 1998, Infection and Immunity.

[136]  R. Lehrer,et al.  Antimicrobial proteins of murine macrophages , 1993, Infection and immunity.

[137]  R. Jurado.  Iron, infections, and anemia of inflammation. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[138]  J. Gabay,et al.  Antibiotic peptides and serine protease homologs in human polymorphonuclear leukocytes: defensins and azurocidin. , 1993, Current opinion in immunology.

[139]  R. Williams,et al.  Bactericidal/Permeability-Increasing Protein Inhibits Growth of a Strain of Acholeplasma laidlawii and L Forms of the Gram-Positive Bacteria Staphylococcus aureus andStreptococcus pyogenes , 1999, Antimicrobial Agents and Chemotherapy.

[140]  J. D. Young,et al.  Perforin: structure and function. , 1995, Immunology today.

[141]  K. Magnússon,et al.  Structure of the gene for porcine peptide antibiotic PR-39, a cathelin gene family member: comparative mapping of the locus for the human peptide antibiotic FALL-39. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[142]  P. Cazenave,et al.  Interaction of NK Lysin, a Peptide Produced by Cytolytic Lymphocytes, with Endotoxin , 1999, Infection and Immunity.

[143]  G. C. Wright,et al.  Bacterial phospholipid hydrolysis enhances the destruction of Escherichia coli ingested by rabbit neutrophils. Role of cellular and extracellular phospholipases. , 1990, The Journal of clinical investigation.